Rebouissou and Nault [43] stated that the main genes whose mutations were implicated in HCC could be classified into six major biological pathways, including telomere maintenance, P53/cell cycle regulation, AKT/mTOR, oxidative stress, etc. It was consistent with the high expression pathway in the high-risk group. The gene discussed is MTOR; the disease is hepatocellular carcinoma.